Efficacy of ORM-12741 for Prevention of Raynaud's Phenomenon
Clinical trial NCT01315899 · TERMINATED
Trial details
- NCT number
- NCT01315899
- Sponsor
- Orion Corporation, Orion Pharma
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-01
- Primary completion
- 2011-12-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.